Bristol-Myers Exec Dug Own Grave With Cover-Up Efforts
By Ian Thoms (August 3, 2012, 8:29 PM EDT) -- Before he allegedly traded on inside information about his employer's potential acquisitions, an executive at Bristol-Myers Squibb Co. searched Yahoo for ways to hide his crime, showing how even supposedly sophisticated defendants can end up damning themselves when trying to cover their tracks, experts say.
Robert Ramnarine, an assistant treasurer for capital markets at the pharmaceutical giant, allegedly bought stock options in three BMS acquisition targets — ZymoGenetics Inc., Pharmasset Inc. and Amylin Pharmaceuticals Inc. — based on private information he learned through his job, according to U.S. Attorney Paul J. Fishman.
Prior to buying options in Pharmasset, Ramnarine allegedly used...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!